Search for products, methods, support...
Cost-efficient flexibility for new and emerging applications.
Kits & Reagents
Reagent kits for the NovaSeq 6000 System provide ready-to-use cartridge-based reagents for cluster generation and SBS
Selection & Planning Tools
Compare sequencing systems and find the right one for your lab or application
Software & Informatics Products
Call, prioritize, and report on variants from one interface
Verify instrument installation and operation, obtain an audit-ready report
Find popular product groupings designed for your workflow
A rapid, sensitive method for profiling accessible chromatin across the genome
By Dr. Phil Febbo, Chief Medical Officer at Illumina
All Investor Information
All Legal Information
Upgrade solution for Illumina systems
All Support Tools
Product Support Services
The Breast Cancer Atlas Project is sequencing more than a million breast cancer cells with the NovaSeq 6000 System
Cancer Genomics Products
Microbial Genomics Research
Learn about eDNA through sequencing the seas
Microbial Genomics Products
International Mungbean Improvement Network Wins Grant
Uncover how chromatin packaging and other factors affect gene expression
Complex Disease Research Products
Dr. Phil Febbo, SVP and Chief Medical Officer
Two next-generation sequencers now available for in vitro diagnostics
Assay targeting multiple variant types, including tumor mutational burden (TMB) and microsatellite instability (MSI), even from low-quality samples.
Scalable throughput and flexibility for virtually any genome, sequencing method, and scale of project.
This is the international website for Illumina. If you are looking for information specific to your region, please select your location and we will redirect you.